Description
A potent, orally bioavailable RORγt inverse agonist; inhibits the expression of IL-17 (at 0.5 µM) and the development and pathogenic function of Th17 cells; reduces the severity of EAE at a daily oral dose of 10 mg/kg,
Formal name: N-[2,6-dichloro-2′-(trifluoromethoxy)[1,1′-biphenyl]-4-yl]-4-(ethylsulfonyl)-benzeneacetamide
Synonyms:
Molecular weight: 532.4
CAS: 1426802-50-7
Purity: ≥98%
Formulation: A crystalline solid